NEW YORK, Nov. 14, 2016 /PRNewswire/ -- The global cell isolation market is expected to reach USD 7.89 billion by 2021 from USD 3.57 billion in 2016, at a CAGR of 17.2%. On the basis of product, the cell isolation market is segmented into consumables and instruments. In 2016, the consumables segment is expected to account for the largest share of the global cell isolation. Growth in this segment can primarily be attributed to the increasing investments by companies to develop advanced products and rising government initiatives for enhancing cell-based research. On the basis of technique, the cell isolation market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. In 2016, the centrifugation-based cell isolation segment is expected to account for the largest share of the global cell isolation market primarily due to the wide usage of this technique among end users. This system is used on a large scale by biotechnology and biopharmaceutical companies as well as on a small scale by clinical research organizations and academia for manufacturing vaccines, enzymes, and antibodies. On the basis of cell type, the cell isolation market is segmented into human cells and animal cells. The human cells segment is expected to account for the largest share of the global cell isolation market during the forecast period. Technological advancements in treatments and increasing incidence of skin diseases are the key factors propelling the growth of this market.On the basis of application, the cell isolation market is segmented into biomolecule isolation, stem cell research, cancer research, in vitro diagnostics, and therapeutics. Increasing company investments to develop new biopharmaceutical products is a major factor contributing to the growth of this market segment. North America is the largest regional segment in the cell isolation market, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is projected to grow at the highest CAGR during the forecast period. Factors such as increasing interest in emerging markets, government support, and high prevalence of diseases are driving the growth of this market.